Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Cellartgen Inc. maintains a portfolio within the Biotechnology & Pharmaceuticals technology area featuring 6 pending office actions. These matters are distributed across 5 distinct art units, suggesting that the company's research and development efforts span several specialized sub-sectors within the broader life sciences field. This distribution requires the applicant to navigate diverse examination standards across multiple administrative divisions at the patent office.
The prosecution workload involves 5 distinct examiners, which introduces a variety of individual perspectives into the portfolio's overall trajectory. THUESON, HANNA MARIE is identified as the busiest examiner for the company, currently handling 2 pending office actions. This concentration makes this specific examiner a significant point of contact for the company's legal representatives.
With 6 pending office actions and only 5 distinct examiners, the portfolio exhibits a high degree of examiner diversity relative to its size. The presence of 5 distinct art units further confirms that the legal strategy must account for varied technical requirements. Practitioners should monitor the 2 pending actions under THUESON, HANNA MARIE to identify potential trends or efficiencies in how the office evaluates the company's biotechnology claims.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THUESON, HANNA MARIE | 2 | 76.7% | +28.2% |
| NICOL, ALEXANDER W | 1 | 42.9% | +43.1% |
| KIPOUROS, HOLLY MICHAELA | 1 | 69.5% | +21.6% |
| MELLER, MICHAEL V | 1 | 47.1% | +28.2% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| BEHARRY, ZANNA MARIA | 1 | 24.7% | +56.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18355798 | DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF | THUESON, HANNA MARIE | — |
| 18347763 | ADIPOSE EXTRACELLULAR MATRIX-DERIVED SCAFFOLD FOR CULTURING ORGANOID AND PREPARING METHOD THEREOF | THUESON, HANNA MARIE | — |
| 18324601 | TISSUE GELL FOR TRANSPLANTATION USING DECELLULARIZED EXTRACELLULAR MATRIX AND METHOD OF PREPARING THE SAME | SCHUBERG, LAURA J | — |
| 18253047 | PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME | BEHARRY, ZANNA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18539379 | MULTI-ORGAN MODEL | NICOL, ALEXANDER W | — |
| 18479843 | MICROFLUIDIC HANGING DROP CULTURE DEVICE FOR CULTURING CELL AGGREGATE | KIPOUROS, HOLLY MICHAELA | — |
| 18475303 | PHENOL DERIVATIVE-MODIFIED, TISSUE-DERIVED EXTRACELLULAR MATRIX DERIVATIVE FOR CONSTRUCTION OF ARTIFICIAL TISSUE | MELLER, MICHAEL V | — |
| 18355798 | DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF | THUESON, HANNA MARIE | — |
| 18347763 | ADIPOSE EXTRACELLULAR MATRIX-DERIVED SCAFFOLD FOR CULTURING ORGANOID AND PREPARING METHOD THEREOF | THUESON, HANNA MARIE | — |
| 18324601 | TISSUE GELL FOR TRANSPLANTATION USING DECELLULARIZED EXTRACELLULAR MATRIX AND METHOD OF PREPARING THE SAME | SCHUBERG, LAURA J | — |
| 18253047 | PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME | BEHARRY, ZANNA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1634 | 1 |
| 1799 | 1 |
| 1655 | 1 |
| 1631 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18539379 | MULTI-ORGAN MODEL | NICOL, ALEXANDER W | 1634 | §102§103DP | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18479843 | MICROFLUIDIC HANGING DROP CULTURE DEVICE FOR CULTURING CELL AGGREGATE | KIPOUROS, HOLLY MICHAELA | 1799 | §103 | Final Rejection | — | Pending | Oct 03, 2023 |
| 18475303 | PHENOL DERIVATIVE-MODIFIED, TISSUE-DERIVED EXTRACELLULAR MATRIX DERIVATIVE FOR CONSTRUCTION OF ARTIFICIAL TISSUE | MELLER, MICHAEL V | 1655 | §112 | Final Rejection | — | Pending | Sep 27, 2023 |
| 18355798 | DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF | THUESON, HANNA MARIE | 1638 | §103§112 | Final Rejection | — | Pending | Jul 20, 2023 |
| 18347763 | ADIPOSE EXTRACELLULAR MATRIX-DERIVED SCAFFOLD FOR CULTURING ORGANOID AND PREPARING METHOD THEREOF | THUESON, HANNA MARIE | 1638 | §102§103 | Final Rejection | — | Pending | Jul 06, 2023 |
| 18324601 | TISSUE GELL FOR TRANSPLANTATION USING DECELLULARIZED EXTRACELLULAR MATRIX AND METHOD OF PREPARING THE SAME | SCHUBERG, LAURA J | 1631 | §103 | Non-Final OA | — | Pending | May 26, 2023 |
| 18253047 | PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME | BEHARRY, ZANNA MARIA | 1632 | §102§112 | Non-Final OA | — | Pending | May 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial